TED Ted Baker Plc

RNS Number:4733Z
Tepnel Life Sciences PLC
03 July 2007



PRESS RELEASE



Tepnel Life Sciences announces completion of its pharmaceutical testing facility
                                  in Scotland



3 July 2007: Tepnel Life Sciences (AIM: TED), the international Molecular
Diagnostics and Research Products and Services group, today announced it has
completed Phase I of its new pharmaceutical testing facility based in
Livingston, Scotland.



Construction commenced on the state-of-the-art laboratory in July 2006 and
operational activity will begin in July this year.  The facility will house 47
staff to be relocated from Tepnel's Edinburgh and Glasgow operations.  It will
accommodate Tepnel's protein analysis and genomic testing laboratories as well
as the Company's analytical chemistry, bioanalysis and microbiology facilities.



Tepnel will initially occupy 14,000sq ft and Phase II development of the
remaining 4000sq ft will begin in September.  This 4000sq ft will house Tepnel's
Molecular Services group which will provide genotyping, whole genome
amplification, sequencing and gene expression services.



Tepnel plans to establish a clinical genotyping operation at Livingston while
continuing its successful development of specialised products and services in
high growth areas such as pharmacogenomics, new generations of vaccines and the
rapidly evolving therapeutic protein market.



Tepnel's Chief Executive Officer, Ben Matzilevich, said: "Our new laboratories
have been built on time and to budget. The facility is an important component of
our long-term strategy that will allow Tepnel to extend its market presence in
the fast-growing biological medicines sector.   Continuity of service to
Tepnel's customers will be maintained throughout the transition to the new
location."



Tepnel's new Livingston facility was part funded by Scottish Enterprise,
Edinburgh and Lothian.



                                     -Ends-





For further information:





Tepnel Life Sciences plc

Ben Matzilevich, CEO
Carol Smith
Tel: 0161 946 2200



Capital MS&L

Mary Clark or Catie Corcoran
Tel: +44 20 7307 5330


Seymour Pierce Limited
Mark Percy
Tel: +44 20 7107 8000



Notes to Editors:


About Tepnel Life Sciences plc


Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees.



Tepnel provides test kits, reagents and services to two highly synergistic
markets, these being Molecular Diagnostics and Biomedical Research.



The company's strategy has been to identify high growth niche opportunities
within these multi-billion pound markets.  Tepnel focuses on these opportunities
with internally developed products, patents, expertise and know-how as well as
strategic acquisitions, to develop a leadership position within these defined
market segments.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCRTMATMMIMBJR

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024